Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4 (vol 38, 409, 2019)-MedSci.cn

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4 (vol 38, 409, 2019)

Zhu, MX; Wei, CY; Zhang, PF; Gao, DM; Chen, J; Zhao, Y; Dong, SS; Liu, BB

Liu, BB (reprint author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Liu, BB (reprint author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, 180 Fenglin Rd, Shanghai 200032, Peoples R China.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4 (vol 38, 409, 2019)

科室

工具

服务